Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Apple
AAPL
|
$975M |
| 2 |
Amazon
AMZN
|
$708M |
| 3 |
UnitedHealth
UNH
|
$634M |
| 4 |
Rivian
RIVN
|
$504M |
| 5 |
TJX Companies
TJX
|
$483M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$1.1B |
| 2 |
NVIDIA
NVDA
|
$814M |
| 3 |
L3Harris
LHX
|
$714M |
| 4 |
Zurn Elkay Water Solutions
ZWS
|
$503M |
| 5 |
Texas Instruments
TXN
|
$468M |
Sector Composition
| 1 | Technology | 32.52% |
| 2 | Healthcare | 18.41% |
| 3 | Consumer Discretionary | 11.42% |
| 4 | Financials | 9.67% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDFN
201
DELISTED
Redfin
RDFN
| $248M | 0.1% |
6,463,304
+230,340
| +4% | +$8.84M |
|
202
Roku
ROKU
$14B
| $247M | 0.1% |
1,082,055
+558,864
| +107% | +$128M |
|
203
Sysco
SYY
$39.4B
| $244M | 0.1% |
3,101,280
-1,322,320
| -30% | -$104M |
|
204
Blackbaud
BLKB
$3.23B
| $241M | 0.1% |
3,056,996
-69,290
| -2% | -$5.47M |
|
205
Marsh & McLennan
MMC
$100B
| $241M | 0.1% |
1,384,670
+594,454
| +75% | +$103M |
|
206
Best Buy
BBY
$16.1B
| $240M | 0.1% |
2,363,686
-356,949
| -13% | -$36.3M |
|
207
Intel
INTC
$107B
| $239M | 0.1% |
4,645,375
+115,280
| +3% | +$5.94M |
|
208
Citigroup
C
$176B
| $239M | 0.1% |
3,956,474
-73,807
| -2% | -$4.46M |
|
209
Cimpress
CMPR
$1.54B
| $238M | 0.1% |
3,320,611
-4,918
| -0.1% | -$352K |
|
210
OneMain Financial
OMF
$7.31B
| $238M | 0.1% |
4,746,371
+416,222
| +10% | +$20.8M |
|
211
HP
HPQ
$27.4B
| $237M | 0.1% |
6,291,947
-3,322,608
| -35% | -$125M |
|
212
Casey's General Stores
CASY
$18.8B
| $237M | 0.1% |
1,199,547
-67,078
| -5% | -$13.2M |
|
213
T Rowe Price
TROW
$23.8B
| $237M | 0.1% |
1,202,919
-328,051
| -21% | -$64.5M |
|
214
Quest Diagnostics
DGX
$20.5B
| $230M | 0.1% |
1,330,191
-177,913
| -12% | -$30.8M |
|
215
Canadian Natural Resources
CNQ
$63.2B
| $226M | 0.09% |
10,913,475
-3,806,198
| -26% | -$78.8M |
|
216
Parker-Hannifin
PH
$96.1B
| $224M | 0.09% |
703,593
+139,423
| +25% | +$44.4M |
|
217
Ligand Pharmaceuticals
LGND
$3.25B
| $223M | 0.09% |
2,310,059
-34,970
| -1% | -$3.37M |
|
218
Otis Worldwide
OTIS
$34.1B
| $220M | 0.09% |
2,525,201
-59,688
| -2% | -$5.2M |
|
219
Euronet Worldwide
EEFT
$3.74B
| $217M | 0.09% |
1,820,306
+7,774
| +0.4% | +$926K |
|
220
Organon & Co
OGN
$2.7B
| $217M | 0.09% |
7,112,393
+1,830,772
| +35% | +$55.7M |
|
221
Insmed
INSM
$30.7B
| $215M | 0.09% |
7,881,558
-106,341
| -1% | -$2.9M |
|
222
Alibaba
BABA
$323B
| $213M | 0.09% |
1,795,747
+1,001,999
| +126% | +$119M |
|
223
Moderna
MRNA
$9.78B
| $213M | 0.09% |
838,195
+167,352
| +25% | +$42.5M |
|
224
Union Pacific
UNP
$131B
| $211M | 0.09% |
837,771
+23,871
| +3% | +$6.01M |
|
225
Mercado Libre
MELI
$123B
| $210M | 0.09% |
155,712
+7,851
| +5% | +$10.6M |
|